Cargando…

Comparison between preoperative and real-time intraoperative planning (125)I permanent prostate brachytherapy: long-term clinical biochemical outcome

BACKGROUND: The purpose of the study is to evaluate the long-term clinical outcome through biochemical no evidence of disease (bNED) rates among men with low to intermediate risk prostate cancer treated with two different brachytherapy implant techniques: preoperative planning (PP) and real-time pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matzkin, Haim, Chen, Juza, German, Larissa, Mabjeesh, Nicola J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904193/ https://www.ncbi.nlm.nih.gov/pubmed/24341548 http://dx.doi.org/10.1186/1748-717X-8-288

Ejemplares similares

Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification
por: Matzkin, Haim, et al.
Publicado: (2019)

A novel greedy heuristic‐based approach to intraoperative planning for permanent prostate brachytherapy
por: Liang, Bin, et al.
Publicado: (2015)

High cancer detection rate using cognitive fusion - targeted transperineal prostate biopsies
por: Dekalo, Snir, et al.
Publicado: (2017)

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
por: Putora, Paul Martin, et al.
Publicado: (2013)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy
por: Lee, Jason Joon Bock, et al.
Publicado: (2022)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

A comparison of preplan MRI and preplan CT-based prostate volume with intraoperative ultrasound-based prostate volume in real-time permanent brachytherapy
por: Park, Hyeli, et al.
Publicado: (2011)

A novel auto‐positioning method in Iodine‐125 seed brachytherapy driven by preoperative planning
por: Ma, Xiaodong, et al.
Publicado: (2019)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer
por: Weksler, Meir, et al.
Publicado: (2023)

Prostate-Specific Antigen Bounce after (125)I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy
por: Inada, Masahiro, et al.
Publicado: (2017)

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
por: Hirose, Katsumi, et al.
Publicado: (2017)

Correlations between intraplan and postplan parameters in I-125 permanent prostate brachytherapy using loose seeds or linked seeds
por: Ito, Fumitaka, et al.
Publicado: (2022)

Inverse planning optimization for hybrid prostate permanent‐seed implant brachytherapy plans using two source strengths
por: Cunha, J. Adam M., et al.
Publicado: (2010)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019)

Benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy
por: Kaljouw, Emmie, et al.
Publicado: (2012)

Toxicity in patients treated with permanent prostate brachytherapy using intraoperatively built custom-linked seeds versus loose seeds
por: Ollivier, Luc, et al.
Publicado: (2020)

Spermatic Vein Tumor Thrombus In Renal Cell Carcinoma
por: Mabjeesh, Nicola J., et al.
Publicado: (2004)

Combination of Permanent Interstitial (125)I-Seed Brachytherapy and Surgery for the Treatment of Large Hepatocellular Carcinoma
por: Li, Xiaogang, et al.
Publicado: (2017)

Plan reproducibility of intraoperatively custom-built linked seeds compared to loose seeds for prostate brachytherapy
por: Kaneda, Tomoya, et al.
Publicado: (2018)

Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
por: Muraki, Koichiro, et al.
Publicado: (2021)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Optimized planning for intraoperative planar permanent‐seed implant
por: Fung, Albert Y. C., et al.
Publicado: (2002)

The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era
por: Savin, Ziv, et al.
Publicado: (2021)

Preoperative planning for intraoperative navigation guidance
por: Sabri, Shahbaaz A., et al.
Publicado: (2021)

Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis
por: Katayama, Norihisa, et al.
Publicado: (2016)

Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy
por: Taira, Al V., et al.
Publicado: (2014)

Effect of constipation on dosimetry after permanent seed brachytherapy for prostate cancer
por: Otón, L. Fernando, et al.
Publicado: (2015)

A comparative evaluation of loading times and exposures for permanent prostate brachytherapy
por: Bice, W. S., et al.
Publicado: (2002)

An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma
por: Shen, Xinying, et al.
Publicado: (2015)

High SEPT9_i1 Protein Expression Is Associated with High-Grade Prostate Cancers
por: Gilad, Roni, et al.
Publicado: (2015)

Pre-plan parameters predict post-implant D(90) ≥ 140 Gy for (125)I permanent prostate implants
por: Alexander, Jes, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6hi9rld9fvoc8ib5jnmvpalc6l